DongKook Pharmaceutical Co. Ltd (086450) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.029x

Based on the latest financial reports, DongKook Pharmaceutical Co. Ltd (086450) has a cash flow conversion efficiency ratio of 0.029x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩22.58 Billion ≈ $15.30 Million USD) by net assets (₩780.60 Billion ≈ $529.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is DongKook Pharmaceutical Co. Ltd's balance sheet to measure how much of total assets are equity-financed.

DongKook Pharmaceutical Co. Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how DongKook Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of DongKook Pharmaceutical Co. Ltd to evaluate the quality of earnings relative to operating cash generation.

DongKook Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of DongKook Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Consolidated Finvest & Holdings Limited NSE:CONSOFINVT	-0.002x
Oasis Crescent Property Fund JSE:OAS	-0.007x
Thuan Duc JSC VN:TDP	0.282x
Novus Holdings Ltd JSE:NVS	0.038x
Kluang Rubber Company Malaya KLSE:2453	-0.001x
SHANGHAI FUDAN H YC-,10 F:FDY	N/A
Quoc Cuong Gia Lai JSC VN:QCG	0.004x
Dimerix Ltd AU:DXB	3.087x

Annual Cash Flow Conversion Efficiency for DongKook Pharmaceutical Co. Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of DongKook Pharmaceutical Co. Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see DongKook Pharmaceutical Co. Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩763.74 Billion ≈ $517.57 Million	₩68.76 Billion ≈ $46.60 Million	0.090x	-19.66%
2024-12-31	₩678.98 Billion ≈ $460.13 Million	₩76.09 Billion ≈ $51.57 Million	0.112x	+54.50%
2023-12-31	₩576.17 Billion ≈ $390.46 Million	₩41.79 Billion ≈ $28.32 Million	0.073x	-11.00%
2022-12-31	₩501.94 Billion ≈ $340.16 Million	₩40.91 Billion ≈ $27.72 Million	0.082x	-17.03%
2021-12-31	₩454.57 Billion ≈ $308.05 Million	₩44.65 Billion ≈ $30.26 Million	0.098x	-31.63%
2020-12-31	₩411.37 Billion ≈ $278.78 Million	₩59.11 Billion ≈ $40.06 Million	0.144x	-24.96%
2019-12-31	₩362.87 Billion ≈ $245.91 Million	₩69.48 Billion ≈ $47.09 Million	0.191x	+80.48%
2018-12-31	₩313.02 Billion ≈ $212.13 Million	₩33.21 Billion ≈ $22.51 Million	0.106x	-2.29%
2017-12-31	₩263.94 Billion ≈ $178.87 Million	₩28.66 Billion ≈ $19.42 Million	0.109x	-34.62%
2016-12-31	₩237.32 Billion ≈ $160.83 Million	₩39.41 Billion ≈ $26.71 Million	0.166x	+22.14%
2015-12-31	₩199.62 Billion ≈ $135.28 Million	₩27.14 Billion ≈ $18.39 Million	0.136x	+5.59%
2014-12-31	₩176.57 Billion ≈ $119.66 Million	₩22.74 Billion ≈ $15.41 Million	0.129x	+5.20%
2013-12-31	₩162.24 Billion ≈ $109.95 Million	₩19.86 Billion ≈ $13.46 Million	0.122x	--

About DongKook Pharmaceutical Co. Ltd

KQ:086450 Korea Pharmaceuticals

Market Cap

$104.24 Million

₩153.82 Billion KRW

Market Cap Rank

#18982 Global

#882 in Korea

Share Price

₩17500.00

Change (1 day)

+2.10%

52-Week Range

₩16420.00 - ₩29900.00

All Time High

₩31498.93